Rasna Therapeutics, Inc.
General ticker "RASP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.5M (TTM average)
Rasna Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -8.0%.
Estimated limits based on current volatility of 0.0%: low 0.00$, high 0.00$
Factors to consider:
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [0.01$, 0.04$]
- 2024-09-29 to 2025-09-29 estimated range: [0.00$, 0.03$]
Financial Metrics affecting the RASP estimates:
- Negative: Non-GAAP EPS, $ of -0.01 <= 0.04
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -0.07 <= 1.76
- Negative: negative Operating income
- Negative: Shareholder equity ratio, % of -2043.48 <= 22.51
- Negative: Industry earnings per price (median), % of -31.04 <= 0
- Positive: Interest expense per share, $ of 0 <= 0.10
- Negative: Industry operating cash flow per share per price (median), % of -25.05 <= 2.83
Short-term RASP quotes
Long-term RASP plot with estimates
Financial data
| YTD | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.53MM | $0.00MM |
| Operating Expenses | $0.25MM | $0.38MM | $4.24MM |
| Operating Income | $-0.25MM | $0.14MM | $-4.24MM |
| Non-Operating Income | $-0.54MM | $-0.83MM | $-0.20MM |
| Interest Expense | $0.52MM | $0.94MM | $0.21MM |
| R&D Expense | $0.06MM | $0.08MM | $0.09MM |
| Income(Loss) | $-0.79MM | $-0.69MM | $-4.44MM |
| Profit(Loss)* | $-1.30MM | $-0.57MM | $-4.44MM |
| Stockholders Equity | $-2.75MM | $-1.69MM | $-1.96MM |
| Inventory | $0.03MM | $0.05MM | $0.00MM |
| Assets | $0.04MM | $0.09MM | $0.10MM |
| Operating Cash Flow | $-0.29MM | $-0.31MM | $-0.01MM |
| Financing Cash Flow | $0.29MM | $0.34MM | $0.04MM |
| Earnings Per Share** | $-0.02 | $-0.01 | $-0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.